News
Transforming outcomes in AML and breast cancer: Three open trials at Providence
10/30/2025
New studies at Providence Cancer Institute offer hope to patients with limited treatment options.
Read-a-thon promotes learning and personalized care for families
The NICU at Providence Portland Medical Center won third place in an international reading competition.
Surgical robot improves care and recovery
10/27/2025
See an inside look at how Providence Portland Medical Center’s da Vinci machine helps surgeons provide safer, faster care to patients.
Newly retired lung cancer survivor receives advanced treatment close to home
10/28/2025
Jim waited until he was 70 to retire from a long and fulfilling career. Then he was diagnosed with lung cancer—twice.
Next generation therapy for men with mCRPC may extend survival
9/29/2025
A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.
Behind the science: Celebrating our cancer research administrator
10/14/2025
Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.
The future of surgery is robotic, and it’s here
8/14/2025
Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.
Meet the 2025 cancer research interns
8/14/2025
Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.
Watch: Virtual health talk on understanding lung cancer
9/24/2025
Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.
A new cancer therapy at Providence helps immune cells stand their ground
9/25/2025
A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.
A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
9/24/2025
A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.
How cold cap therapy prevented patient’s hair loss during cancer treatment
6/3/2025
What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.